Clinical Trials Sponsored by BaroNova, Inc

Total 35412 results

BaroNova, Inc.

Completed

ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss

Obesity

United States
BaroNova, Inc.

Completed

A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects

Obesity

Australia
VasoNova, Inc.

Completed

Use of the VasoNova VPS System During PICC Placement in an Algorithm Confirmation Study Using Fluoroscopy

Any Condition Requiring a PICC Placement

United States
Aronora, Inc.

Completed

Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects

Thrombosis

United States
Aronora, Inc.

Completed

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

Thrombosis | End Stage Renal Disease

United States
Aronora, Inc.

Completed

Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects

Thrombosis

United States
Aronora, Inc.
Celerion

Completed

Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Thrombosis | End Stage Renal Disease

United States
Pronova BioPharma

Completed

Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects

Healthy

United Kingdom
Pronova BioPharma

Completed

Bioavailability of Omega-3 Food Supplements in Healthy Subjects

Healthy

United Kingdom
Pronova BioPharma

Completed

[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study

Healthy

United Kingdom
Pronova BioPharma

Completed

The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects

Dyslipidemia

United States
Pronova BioPharma

Completed

Bioavailability of Omega-3 Food Supplement in Healthy Subjects

Biological Availability

United Kingdom
Pronova BioPharma

Completed

Omacor and Placebo in Carotid Plaque Stability

Cardiovascular Disease

United Kingdom
Pronova BioPharma

Terminated

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States
Pronova BioPharma

Completed

PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study

Healthy

United Kingdom
Bronovo Hospital

Completed

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

Hip Fracture | Post-Operative Delirium

Netherlands
Pronova BioPharma
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients

Non Alcoholic Fatty Liver

United States
BioNova Pharmaceuticals (Shanghai) LTD.

Terminated

Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Follicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma

China
BioNova Pharmaceuticals (Shanghai) LTD.

Withdrawn

A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL

NHL | CLL/SLL

China
BioNova Pharmaceuticals (Shanghai) LTD.

Completed

Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)

GVHD, Chronic

China
Northumbria University
Pronova BioPharma

Completed

The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

Cognitive Function

United Kingdom
Northumbria University
Pronova BioPharma

Completed

Plasma Diurnal Variation in and Absorption of EPA and DHA

Lipid Absorption and Metabolism

United Kingdom
BioNova Pharmaceuticals (Shanghai) LTD.

Recruiting

A Study of BN104 in the Treatment of Acute Leukemia

AML, Adult | ALL, Adult

China
Nordlandssykehuset HF
Pronova BioPharma

Completed

Effect of Omega-3 Fatty Acid on Endothelial Function

Familial Hypercholesterolemia

Norway
Northumbria University
Pronova BioPharma

Completed

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults

Neurovascular Coupling

United Kingdom
Penn State University
Pronova BioPharma

Completed

Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation (PRONOVA)

Inflammatory Responses

United States
Pronova BioPharma
Aalborg University Hospital

Completed

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Ischemic Heart Disease | Human Immunodeficiency Virus

Denmark
Marinova Pty Ltd
University of South Carolina; Nutrasource Pharmaceutical and Nutraceutical...

Completed

Inflammatory and Immune Response After High Intensity Exercise

Inflammatory Response

United States
Bornova No. 25 Mevlana Family Health Center

Completed

The Effect of ShotBlocker on Injection Pain

Pain | Intramuscular Injection

Turkey
V.A. Nasonova Research Institute of Rheumatology...
AstraZeneca

Not yet recruiting

Evaluation of Type I IFN Level and Disease Activity in SLE Patients

Elevated Level of IFN Type I in SLE Patients
Kuhnil Pharmaceutical Co., Ltd.
Pronova BioPharma ASA

Completed

Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy (IgAN)

IgA Nephropathy

Korea, Republic of
Abbott
Rundo-Cronova International Pharmaceuticals Research & Development Co., Ltd.

Completed

Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Anesthesia, General

China
Stiftung Institut fuer Herzinfarktforschung
Pronova BioPharma; Trommsdorff GmbH & Co. KG

Completed

OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction (OMEGA)

Myocardial Infarction

Germany
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
National Center for Complementary and Integrative...
Pronova BioPharma

Completed

Omega-3 Fatty Acids in Bipolar Disorder

Bipolar Disorder

United States
Pronova BioPharma
Danish Heart Foundation; The Danish Kidney Association; North Jutland County

Completed

Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis

Kidney Failure, Chronic

Denmark
The Swedish School of Sport and Health Sciences
The Knowledge Foundation; SATS; Itrim; Avonova

Not yet recruiting

Exercise Intensity on Brain & Mental Health in Stress (ExStress)

Healthy Adults | Adults With Stress-related Symptoms

Sweden
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Helse Stavanger HF
University of Oslo; University of Bergen; Pronova BioPharma; Pharmacia and Upjohn

Completed

Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction (OFAMI)

Myocardial Infarction | Coronary Disease

Norway
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
Oslo University Hospital
Aarhus University Hospital; Aalborg University Hospital; South-Eastern Norway... and other collaborators

Completed

The Effects of Omega-3 Fatty Acids in Renal Transplantation (ORENTRA)

Disorder Related to Renal Transplantation

Norway
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States

Clinical Trials Sponsored by BaroNova, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations